can you take pain meds with semaglutide I painkillers while on Wegovy? Semaglutide GLP-1 Injections for Weight
Description
ISME J 1:156162
The study may be underpowered and to short to detect changes in cancer rates
The FDA label specifically warns about the risk of cholelithiasis, noting that substantial or rapid weight loss itself is an established risk factor for gallstone formation
According to company materials, this represents an FDA-approved oral GLP-1 option for weight management, offering an alternative to injectable formats for patients with needle aversion
As a result, only 24% of diabetes patients remain persistent with GLP-1 therapy after one year
The combination of decreased glucose uptake by the muscle and decreased glycogenesis further contributes to hyperglycemic conditions and complicates the already challenging task of treating cancer in individuals managing diabetes
